Counsyl Stock
Health Technology Company
Sign up today and learn more about Counsyl Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Counsyl Stock
Counsyl is a genetic screening and counseling services company. The company provides women and their families with actionable information to guide health decisions. Counsyl operates a clinical laboratory that offers the Foresight™ Carrier Screen, Prelude™ Prenatal Screen and Reliant™ Cancer Screen, and supporting services through Counsyl Complete™, a proprietary suite of solutions, each designed to integrate into clinic workflows and patients’ lives. Their genetic screens provide actionable information to patients and their healthcare providers through process that facilitates clinical decision-making.
The company launched their first commercial screen in 2009, and in January 2018, reached a milestone of having delivered one million patient results.
How Counsyl Works
Source: Counsyl
Investors
Felicis Ventures
Wish, Scopely, Opendoor, Dollar Shave Club, Gusto, Coalition, Zipline, Plaid, Crusoe Energy Systems, Guild Education
Founders Fund
Lyft, SpaceX, Spotify, Airbnb, Stripe, Anduril Industries, Flexport, Palantir Technologies, Wish, Compass
Goldman Sachs
WeWork, Alibaba, Spotify, Compass, Pinterest, Bloom Energy, Oscar Health, Circle, Automation Anywhere, Zymergen
Great Oaks Venture Capital
Acorns, Bolt Financial, Workrise, Collective Health, Course Hero, SingleStore, Virta Health, Human Interest, Maven Clinic, Petal
Funding History
| June 2010 | $7.5M |
|---|---|
| November 2011 | $36.1M |
| August 2012 | $8.2M |
| May 2014 | $50.0M |
Management
Co-Founder & Chief Executive Officer
Ramji Srinivasan
Co-Founder & Chief Science Officer
Eric Evans
Chief Medical Officer
James Goldberg, PhD
Chief Financial Officer
Joel Jung
Chief Commercial Officer
Noah Nasser
Co-Founder & SVP, Technology
Rishi Kacker
Press
hcanews.com - Feb, 2 2018
Counsyl's 1M Genetic Screens Underscore Popularity of TestingBusiness Wire (press release) - Jan, 30 2018
Counsyl Surpasses One Million Genetic ScreensBusiness Wire (press release) - Jan, 16 2018
Counsyl Secures Approval From New York State Department of ...Business Wire (press release) - Jan, 4 2018
Counsyl Appoints Ann Rhoads to Board of Directors | Business WireBusiness Wire (press release) - Dec, 14 2017
Counsyl Appoints Pamela Sedmak to Board of DirectorsBusiness Wire (press release) - Dec, 4 2017
Counsyl Appoints Noah Nasser as Chief Commercial OfficerGenomeWeb - Nov, 6 2017
Counsyl Raises $80MBusiness Wire (press release) - Sep, 11 2017
Counsyl Experts to Speak and Present Research at National Society of Genetic Counselors (NSGC) Annual ConferenceNews-Medical.net - Jul, 25 2017
Counsyl unveils significant enhancements to expanded carrier screening panelBusiness Wire (press release) - Jul, 19 2017
Counsyl Announces Industry Leading Enhancements to Expanded Carrier Screening PanelBusiness Wire (press release) - Jul, 10 2017
Counsyl and Angsana Bring Expanded Carrier Screening to Clinicians and Patients in Hong KongBusiness Wire (press release) - May, 3 2017
Explore the Latest in Carrier Screening with Counsyl at the 2017 ACOG Annual Clinical and Scientific MeetingBusiness Wire (press release) - Apr, 26 2017
SYNLAB and Counsyl Enter Into Agreement to Offer Genetic Screening for Serious Inherited Health Conditions in ...GenomeWeb - Mar, 29 2017
Perthera Partners With Counsyl to Offer Germline Testing of Cancer PatientsBusiness Wire (press release) - Jan, 6 2017
Counsyl Strengthens Focus on Preventive Genetic Testing for Women's HealthThe MIT Technology Review - Mar, 16 2015
A Contrarian in BiotechEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
